NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,240 | -2.6% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,430 | +7.2% | 1,000 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $6,930 | -32.7% | 1,000 | -0.2% | 0.00% | -42.9% |
| Q4 2022 | $10,301 | -43.5% | 1,002 | 0.0% | 0.01% | -56.2% |
| Q3 2022 | $18,236 | -82.3% | 1,002 | -50.0% | 0.02% | -81.0% |
| Q2 2022 | $102,963 | -30.5% | 2,002 | -0.5% | 0.08% | -30.6% |
| Q1 2022 | $148,184 | -74.2% | 2,012 | -49.9% | 0.12% | -74.5% |
| Q4 2021 | $573,997 | – | 4,012 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |